Idiopathic pulmonary fibrosis (IPF) affects hundreds of thousands of people worldwide,
reducing their quality of life and leading to death from respiratory failure within years of …

IPF is a fatal lung disease characterized by intensive remodeling of lung tissue leading to
respiratory failure. The remodeling in IPF lungs is largely characterized by uncontrolled …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease for which two
antifibrotic drugs recently were approved. However, an unmet need exists to predict …

Background The major causes of morbidity and mortality of patients with chronic liver
disease are liver fibrosis and cirrhosis. Previous studies have been concerned with immune …

It is well established that there exist comprehensive interactions between tumor immunology
and tumor biology. Tumor-infiltrating immune cells (TIICs) have been appealing therapeutic …

Introduction Heart failure (HF) secondary to acute myocardial infarction (AMI) is still a
worldwide problem with a high mortality rate. The current study aimed to explore early and …

Idiopathic pulmonary fibrosis (IPF) is an aggressive interstitial lung disease associated with
progressive and irreversible deterioration of respiratory functions that lacks curative …

Recent studies have suggested that an increased peripheral monocyte count predicts a poor
outcome in fibrosing interstitial lung disease (ILD). However, the association between an …

Metabolic reprogramming contributes to patient prognosis. Here, we aimed to reveal the
comprehensive landscape in metabolism of head and neck squamous carcinoma (HNSCC) …

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are the leading cause of
mortality among patients with IPF. There is still a lack of effective treatments for AE-IPF …